One-shot ovarian stimulation protocol for fertility
Part of Women’s health & pregnancy clinical trials.
This trial tests a 'one-shot' ovarian stimulation protocol (a single injection to help your ovaries produce eggs). It is for women with good ovarian reserve who fit certain age and health requirements, and aims to simplify the treatment process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or younger.
- Your ovarian reserve (AMH or AFC) is in a specific range that shows a good response to stimulation.
- You have no family history of inherited or chromosomal conditions.
- Your body mass index (BMI) is between 18 and 30.
- You are willing to try a one-time ovarian stimulation protocol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different medications (Corifollitropin alpha and daily rFSH) to stimulate egg production in healthy egg donors. It aims to see if a single injection of Corifollitropin alpha works as well as the usual daily shots, making the process simpler and more comfortable.
This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.
This trial studies whether a “mechanical stimulation” procedure can help small egg-making structures in the ovary start to work again in people with primary ovarian insufficiency. If the procedure shows signs of response, you may then move on to further fertility treatment, including IVF.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.